Skip to main content

Advertisement

Table 2 Patients with latent Herpes infections.

From: GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes

patient sex age virus Site of infection Also treated for active infection? Inhibition of outbreak whilst on maintenance dose? Comments
1 M* (1) 50 HSVI Orolabial Yes Existing lesion healed. Yes, inhibition of further outbreaks on maintenance dose >2 years. Varied dosage, consistent inhibition.
2 F* (3) 72 HSVI prodrome Orolabial (prodrome) and ocular conjunctiva Yes, no progression to lesion Yes, continued Inhibition of low grade conjunctival HSVI for three months Notes improvement in skin condition.
3 F* (13) 85 Zoster (shingles) Torso Yes Yes, inhibition for two months. Relief from lesions requires 4 capsules per day
4 F* (9) 42 HSVII Genital Yes. Existing lesion healed. Yes, inhibition of further outbreaks on maintenance dose 3 months. Prior two weekly outbreaks of ACV resistant strain of HSVII.
5 F 41 HSVII Genital No(not taken during active infection) Yes, inhibition on two capsules per day for 1 month. Did not take during active lesion outbreak.
6 F 36 HSVII Genital No(not taken during active infection) Yes, inhibition on two capsules per day for 1 month. Did not take during active lesion outbreak.
  1. * the number in brackets refers to the number assigned to the same patient in table 1.